Clinical Trials Browser

Phase 2 × Solid Tumor × pembrolizumab × Clear all

NCT05642780 2025-10-14

SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor